Alumis Inc. (ALMS)
NASDAQ: ALMS · Real-Time Price · USD
26.40
+1.37 (5.47%)
At close: Jun 26, 2026, 4:00 PM EDT
26.21
-0.19 (-0.72%)
After-hours: Jun 26, 2026, 7:32 PM EDT
Alumis Employees
As of March 31, 2026, Alumis had 227 total employees, including 225 full-time and 2 part-time employees. The number of employees increased by 3 or 1.34% since the number was last reported on December 31, 2025.
Employees
227
Change
3
Growth
1.34%
Revenue / Employee
$37,013
Profits / Employee
-$1,045,881
Market Cap
3.37B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 227 | 3 | 1.34% |
| Dec 31, 2025 | 224 | 54 | 31.76% |
| Dec 31, 2024 | 170 | 61 | 55.96% |
| Dec 31, 2023 | 109 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Telix Pharmaceuticals | 1,184 |
| Beam Therapeutics | 522 |
| Arcutis Biotherapeutics | 354 |
| Vera Therapeutics | 339 |
| Dyne Therapeutics | 263 |
| Structure Therapeutics | 233 |
| uniQure | 221 |
ALMS News
- 1 day ago - Alumis management to meet with Cantor - TheFly
- 15 days ago - Alumis rises 10.3% - TheFly
- 5 weeks ago - Alumis price target raised to $40 from $38 at Chardan - TheFly
- 5 weeks ago - Alumis Proxy statement: Proxy filing - Filings
- 5 weeks ago - Alumis Proxy statement: Proxy filing - Filings
- 6 weeks ago - Alumis price target raised to $39 from $38 at Morgan Stanley - TheFly
- 6 weeks ago - Alumis price target raised to $51 from $49 at Wells Fargo - TheFly
- 6 weeks ago - Alumis Slides: Corporate presentation - Filings